Atlas Trials

Dexmedetomidine Supplemented Analgesia and Delirium After Hip Fracture Surgery

Clinical trial NCT04955249 · TERMINATED

Trial details

NCT number
NCT04955249
Sponsor
Peking University First Hospital
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
ElderlyHip Fracture SurgeryPatient-controlled AnalgesiaDexmedetomidinePostoperative Delirium
Start date
2021-11-18
Primary completion
2023-04-11
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.